Majority of Cancer Drugs with Accelerated FDA Approval Did Not Show Clinical Benefit After 5 Years
Researchers were unable to find a significant benefit for patients for the majority of cancer medications given accelerated FDA approval.
Is E-Prescribing the Future of Veterinary Medicine?
Wendy Crouse, DVM, an independent house call veterinarian with Heal House Call Veterinarian, sat down with Drug Topics to discuss how the adoption of e-prescribing has transformed her practice.
Congress, CMS Must Take Action to Mitigate Impact of ‘DIR Hangover’
A Q&A with Douglas Hoey, CEO of NCPA, on how the new provision from CMS requiring DIR fees at the point of sale is impacting independent pharmacies in 2024.
The Importance of Continuing Education in Pharmacy Compounding
Kevin Hope, RPh, senior director of pharmacy education at Pharmcon, joined Drug Topics to discuss pharmacy compounding from the new USP changes and the importance of education around compounding best practices.
Should Pharmacists Conduct Mental Health Evaluations?
With an unprecedented number of Americans in need of mental health care, what role should pharmacists play when it comes to screenings?
Judge Rules in Favor of Eli Lilly on Insulin Pricing Settlement
With the judge’s failure to approve a settlement class, a $13.5 million settlement against Eli Lilly was called off.
